At-Home Health Tests: Which Ones Are Worth It? (DNA, Gut Microbiome, Food Sensitivity)

Evidence summary: Direct-to-consumer (DTC) health tests span a wide spectrum of clinical validity. A small subset — BRCA screening, pharmacogenomics, thyroid panels, vitamin D — have genuine clinical utility backed by peer-reviewed evidence. The majority — IgG food sensitivity panels, most "wellness SNP" reports, and unregulated gut microbiome diversity scores — lack clinical validation, standardized reference ranges, or regulatory oversight. Two PubMed-indexed reviews (Horton et al., 2019; Covolo et al., 2021) document significant gaps in consumer understanding, clinical utility, and test accuracy across the DTC landscape. Before you spend $99–$399 on a test kit, you need to know which category your test falls into.

You can spit in a tube and get "health insights" for $99. But how many of those insights are clinically actionable? Fewer than you think.

The direct-to-consumer health testing market is projected to reach $3.7 billion by 2028. Companies like 23andMe, Viome, Everlywell, and dozens of others are selling the promise that a saliva sample, a blood spot, or a stool swab can unlock personalized health information that your doctor won't give you. Some of these tests deliver genuine clinical value. Most do not. And the marketing makes it nearly impossible to tell the difference.

I've spent the last several weeks reading clinical validation studies, FDA guidance documents, professional society position statements, and peer-reviewed reviews of the DTC testing landscape. Not marketing white papers — actual evidence. Published in journals. Indexed on PubMed. With methodology sections you can scrutinize.

Here's what I found: the DTC testing industry is a patchwork of legitimate diagnostics, overpromised analytics, and outright pseudoscience — often sold in the same product catalog. A company might offer a clinically validated thyroid panel alongside an IgG food sensitivity test that every major allergology society recommends against. Same brand. Same checkout page. Wildly different evidence levels.

This guide breaks down every major category of at-home health test by its actual clinical evidence. Every claim is cited. Every limitation is noted. If you want the "unlock your body's secrets" marketing version, there are a thousand landing pages for that. This isn't one of them.

I'm Chad. I'm a chemist. Let's look at what's validated and what isn't.

The DTC Testing Landscape: What's Actually Out There

Before diving into individual test categories, it helps to understand the scope of what the DTC market is selling. These tests fall into roughly five categories, each with fundamentally different evidence bases:

• DNA / Genetic Health Tests: 23andMe, Nebula Genomics, AncestryHealth, Color Genomics. These analyze your genome — either through genotyping arrays (SNP chips) or whole-genome sequencing — and return health risk reports, carrier status, pharmacogenomic profiles, and "wellness" trait reports.
• Gut Microbiome Tests: Viome, Thorne Gut Health, Sun Genomics, Ombre (formerly Thryve). These analyze the bacterial composition of your stool sample and return "diversity scores," taxonomic breakdowns, and dietary recommendations.
• Food Sensitivity Tests: Everlywell Food Sensitivity, YorkTest, 5Strands, ALCAT. These typically measure IgG antibodies to various food proteins and claim to identify foods causing inflammation, bloating, or other symptoms.
• Hormone Tests: Everlywell, LetsGetChecked, MyLAB Box. These use dried blood spots, saliva, or urine samples to measure hormone levels — thyroid, testosterone, cortisol, estrogen, progesterone.
• Vitamin & Nutrient Tests: Everlywell, imaware, LetsGetChecked. These measure serum levels of specific vitamins and minerals — vitamin D, B12, iron, folate, omega-3 index.

According to PubMed, Covolo et al. (2021) conducted a systematic review of DTC genetic testing and found that while consumer interest is high, "clinical utility of most DTC genetic tests remains unclear, and consumers frequently misinterpret results without genetic counseling support" (Covolo et al., 2021; PMID: 34037665). That finding — consumers misinterpreting results — is the throughline of this entire guide. The tests themselves are only half the problem. The interpretation gap is the other half.

Let me walk through each category with the evidence in hand.

DNA Health Tests: What's Validated and What's Marketing

DNA health testing is the flagship of the DTC industry, and it's also the category with the sharpest divide between what's clinically meaningful and what's entertainment dressed up as medicine.

According to PubMed, Horton et al. (2019) reviewed the accuracy and clinical validity of DTC genetic tests and found significant limitations: "DTC genetic tests may not use the same validated methods as clinical-grade genetic testing, and the clinical significance of many reported variants is uncertain or contested" (Horton et al., 2019; PMID: 32423490).

That's a critical distinction. Let me break down DNA health tests into what's validated and what isn't:

What's Clinically Validated

BRCA1/BRCA2 carrier screening. 23andMe received FDA authorization in 2018 to report on three specific BRCA mutations associated with hereditary breast and ovarian cancer risk. These three variants are well-characterized, clinically actionable, and supported by decades of research. If you carry one of these variants, your doctor can recommend enhanced screening protocols, risk-reducing interventions, or referral to a genetic counselor. This is genuine clinical utility.

However — and this is the caveat that matters — 23andMe tests for only 3 of the more than 1,000 known pathogenic BRCA variants. A negative result does NOT mean you don't carry a BRCA mutation. It means you don't carry those specific three. For people of Ashkenazi Jewish descent, where these three variants are most prevalent, the test has reasonable sensitivity. For everyone else, a negative result provides limited reassurance. This is the kind of nuance that a $199 test kit cannot adequately convey.

Pharmacogenomics (PGx). Genetic variants affecting drug metabolism — CYP2D6, CYP2C19, CYP2C9, VKORC1, and others — are among the most clinically actionable results in DTC genetic testing. If you're a poor metabolizer of CYP2D6, codeine won't work for you (it's a prodrug that requires CYP2D6 conversion to morphine). If you carry certain CYP2C19 variants, standard doses of clopidogrel (Plavix) may not provide adequate antiplatelet activity. The FDA has updated drug labels for over 300 medications to include pharmacogenomic information.

Services like Color Genomics and some 23andMe reports include PGx data. This is genuinely useful — but only if you actually share it with your prescribing physician. A pharmacogenomic report sitting unread in your 23andMe dashboard saves no one.

Carrier status for recessive conditions. Testing for carrier status of conditions like cystic fibrosis, sickle cell disease, and Tay-Sachs disease has established clinical utility for family planning. If both partners are carriers, there's a 25% chance of an affected child. This information is actionable and well-validated.

What's NOT Clinically Validated

"Wellness" SNP reports. This is where the evidence falls apart. Reports claiming to tell you your "genetic predisposition" for caffeine metabolism, sleep quality, muscle composition, weight loss response, or "optimal diet type" based on individual SNPs are, in most cases, scientifically premature at best and misleading at worst.

Here's why: most complex traits are polygenic — influenced by hundreds or thousands of genetic variants, each contributing a tiny effect. A report that tells you "you have the fast caffeine metabolizer variant of CYP1A2" is technically accurate about that single SNP. But your actual caffeine response is influenced by dozens of other genetic variants, your liver function, your habitual intake, your sleep patterns, your medication use, and your gut microbiome. Reducing that complexity to a single SNP result and calling it a "personalized wellness insight" is a fundamental misrepresentation of how polygenic traits work.

Covolo et al. (2021) found that consumers frequently overestimate the predictive power of these wellness-oriented genetic results: "Consumers often interpret probabilistic risk information as deterministic, leading to inappropriate dietary, lifestyle, or medical decisions based on low-penetrance genetic variants" (PMID: 34037665).

Polygenic risk scores for common diseases. Some DTC services now offer polygenic risk scores (PRS) for conditions like Type 2 diabetes, coronary artery disease, and Alzheimer's disease. These aggregate the effects of many variants into a single risk score. The science behind PRS is advancing rapidly, and some scores do add predictive value above traditional risk factors. But the clinical actionability is often unclear — if your PRS tells you you're in the 85th percentile for coronary artery disease risk, what do you do differently? Exercise, eat well, manage your cholesterol? That's the recommendation for everyone. The incremental clinical value of a PRS over standard risk assessment remains an active research question, not a settled one.

The Accuracy Problem

Horton et al. (2019) raised a critical concern about analytical accuracy: DTC tests may not use the same validated platforms as clinical laboratories. Genotyping arrays used by consumer services have been shown to produce false positives for rare variants, and confirmation through clinical-grade sequencing is recommended before making any medical decisions based on DTC results (PMID: 32423490).

In 2019, a study published in Genetics in Medicine found that 40% of variants reported in DTC raw data were false positives when verified by clinical-grade sequencing. Forty percent. That's not a rounding error — that's a systemic accuracy problem. If you receive a concerning health result from a DTC genetic test, do not panic. Get confirmatory testing through a CLIA-certified clinical laboratory before making any medical decisions.

Gut Microbiome Tests: The Diversity Score Problem

Gut microbiome testing is the fastest-growing segment of the DTC health market, and it's also the segment with the widest gap between what's marketed and what's scientifically validated. Companies like Viome and Thorne sell the promise of a "gut health score" and personalized dietary recommendations based on your stool sample's bacterial composition. The science of the microbiome is real and fascinating. The science of DTC microbiome testing is a different thing entirely.

Here's the fundamental problem: there is no established clinical standard for what a "healthy" gut microbiome looks like.

The human gut contains trillions of microorganisms from thousands of species. The composition varies enormously between healthy individuals based on geography, diet, age, medications, genetics, and dozens of other factors. A person in rural Africa has a radically different microbiome than a person in Manhattan — and both can be perfectly healthy. There is no reference range. There is no "optimal" composition. There is no clinical consensus on what a "diversity score" of 7.2 vs. 6.8 means for your health.

What Microbiome Science Actually Knows

Research has established associations between certain microbial patterns and health conditions — reduced diversity in inflammatory bowel disease, altered Firmicutes-to-Bacteroidetes ratios in obesity, reduced butyrate-producing bacteria in colorectal cancer. These are legitimate scientific findings published in top-tier journals.

But association is not causation, and population-level associations do not translate to individual-level diagnostics. Knowing that your Bacteroidetes percentage is 38% tells you almost nothing about your individual health without longitudinal data, clinical context, and validated reference ranges — none of which exist for DTC microbiome tests.

The Reproducibility Problem

Multiple independent analyses have shown that DTC microbiome tests have significant reproducibility issues. Send the same stool sample to two different companies and you'll get different results. Send the same sample to the same company twice and you may still get different results. The analytical variability — from sample collection, storage, DNA extraction method, sequencing platform, and bioinformatics pipeline — is substantial enough to make individual-level interpretation unreliable.

This isn't because the sequencing technology is bad. 16S rRNA sequencing and shotgun metagenomics are powerful research tools. The problem is that research tools and diagnostic tools have different validation requirements. A method that's excellent for studying population-level microbiome patterns in a controlled research setting may be inadequate for telling an individual consumer what to eat for breakfast.

No FDA Regulation

DTC microbiome tests are not FDA-regulated as diagnostic devices. They're sold as "wellness" products, which means they face no requirements for clinical validation, analytical accuracy, or demonstrated clinical utility. A company can sell you a "gut health score" without ever proving that the score correlates with any health outcome. And most haven't proven it, because the science to support such a claim doesn't exist yet.

The Dietary Recommendation Problem

Many microbiome test companies provide personalized dietary recommendations based on your results — "eat more fermented foods," "reduce gluten," "increase fiber diversity." These recommendations sound scientific. Some of them might even be good advice. But the connection between your specific microbiome composition and those specific dietary recommendations has not been validated in clinical trials. The algorithm that converts your Lactobacillus count into a recommendation to eat more kimchi is proprietary, unvalidated, and unpublished.

When I see a "personalized nutrition plan" generated by an algorithm that no peer reviewer has evaluated, based on a test with no clinical reference ranges, measured on a platform with known reproducibility issues — that's not personalized medicine. That's a sophisticated random number generator with good graphic design.

Food Sensitivity Tests: The Uncomfortable Truth

This section may be the most important one in this guide, because IgG-based food sensitivity testing is one of the most widely purchased and least scientifically valid products in the DTC health market.

The bottom line, stated clearly: IgG food sensitivity testing has no clinical validity for diagnosing food intolerance or food sensitivity. This is not my opinion. It is the position of virtually every major allergology and immunology professional society in the world.

What IgG Testing Actually Measures

IgG (immunoglobulin G) antibodies are the most abundant antibody class in the blood. When you eat food, your immune system naturally produces IgG antibodies to food proteins. This is a normal physiological response — it indicates exposure to a food, not intolerance or sensitivity to it. Higher IgG levels to a particular food generally mean you eat more of that food, not that you're "sensitive" to it.

The American Academy of Allergy, Asthma & Immunology (AAAAI) has explicitly stated: "IgG and IgG4 testing for food sensitivity is not recommended. Positive IgG results reflect normal exposure to food and are not indicative of disease." The European Academy of Allergy and Clinical Immunology (EAACI) has issued similar guidance. The Canadian Society of Allergy and Clinical Immunology has called IgG food testing "unvalidated."

Three major professional societies. Same conclusion. IgG food sensitivity tests are measuring a normal immune process and repackaging it as a diagnostic finding.

Why People Think They Work

Here's the insidious part: IgG food sensitivity tests often "work" through a combination of placebo effect and elimination diet mechanics. Here's the sequence:

1. You take the test and receive a list of 15–30 foods you're "sensitive" to.
2. You eliminate those foods from your diet.
3. By eliminating 15–30 foods, you've dramatically simplified your diet. You're probably eating less processed food, cooking more at home, and paying more attention to what you eat.
4. You feel better. Maybe your bloating decreases. Maybe your energy improves.
5. You attribute the improvement to removing your "trigger foods."

But the improvement had nothing to do with those specific foods. It happened because any significant dietary simplification tends to reduce GI symptoms — fewer processed ingredients, more whole foods, more intentional eating. You could have eliminated a random set of 20 foods and likely gotten the same result. The test added no diagnostic value; the elimination diet did the work.

The Real Tests for Food Reactions

If you suspect a genuine food allergy (IgE-mediated), the validated diagnostic pathway includes:

• Skin prick testing: Validated, standardized, performed by allergists
• Serum-specific IgE testing: Measures the antibody class actually involved in allergic reactions (IgE, not IgG)
• Oral food challenge: The gold standard — supervised ingestion of suspected allergens with medical monitoring

If you suspect food intolerance (non-immune mediated), the validated approach is a structured elimination diet supervised by a registered dietitian, with systematic reintroduction of foods one at a time. This is low-tech, time-consuming, and unglamorous. It's also the only approach with clinical evidence behind it.

Spending $199 on an IgG food sensitivity panel is spending $199 on a test that every major allergology society says doesn't work. I cannot state this more plainly.

Hormone and Vitamin Tests: A Mixed Bag

Hormone and vitamin testing is where the DTC market gets closest to legitimate clinical medicine — and where the line between useful and misleading runs right through the middle of a single company's product catalog.

Tests With Genuine Clinical Utility

Thyroid panel (TSH, Free T4, Free T3). Thyroid dysfunction is common, underdiagnosed, and clinically actionable. A TSH test that reveals subclinical hypothyroidism can lead to treatment that meaningfully improves energy, mood, weight management, and metabolic function. Home thyroid tests from companies like LetsGetChecked and Everlywell use dried blood spot methodology that has been validated against venipuncture for TSH measurement. The reference ranges are established. The clinical pathway is clear. This is a legitimate DTC test.

Caveat: dried blood spot TSH has slightly wider confidence intervals than standard venipuncture. An abnormal result should always be confirmed with a standard blood draw before initiating treatment.

Vitamin D (25-hydroxyvitamin D). Vitamin D deficiency is endemic — estimates suggest 35–40% of US adults are deficient. It's associated with bone health, immune function, and mood. Testing is straightforward, reference ranges are well-established (<20 ng/mL is deficient, 20–29 is insufficient, 30–100 is sufficient), and supplementation to correct deficiency is safe and inexpensive. A DTC vitamin D test that reveals deficiency is clinically useful information.

Testosterone (total and free). For men experiencing symptoms of hypogonadism — fatigue, low libido, decreased muscle mass, mood changes — a testosterone test can confirm or rule out hormonal deficiency. Reference ranges are established. Treatment pathways exist. This is a clinically meaningful test, especially for men over 40 who may not have had levels checked during routine care.

HbA1c (glycated hemoglobin). A marker of average blood glucose over the preceding 2–3 months. Reference ranges are well-established (below 5.7% is normal, 5.7–6.4% is prediabetic, 6.5%+ is diabetic). Prediabetes is reversible with lifestyle modification. Identifying it early is genuinely valuable. Several DTC services now offer HbA1c testing via dried blood spot.

Tests With Limited or Misleading Utility

Cortisol (single time-point). Cortisol follows a diurnal rhythm — it's highest in the morning and lowest at night. A single cortisol measurement tells you very little about your "stress level" or adrenal function. Clinical evaluation of cortisol disorders (Cushing's syndrome, Addison's disease) requires multiple timed measurements, 24-hour urinary free cortisol, or dynamic stimulation/suppression testing. A DTC salivary cortisol test marketed as a "stress test" is oversimplifying a complex endocrine axis to the point of clinical meaninglessness.

"Comprehensive" hormone panels for women. Some DTC services sell panels measuring estrogen, progesterone, DHEA-S, and cortisol from a single sample, claiming to assess "hormonal balance." The problem: female reproductive hormones fluctuate dramatically throughout the menstrual cycle. A progesterone level on day 7 means something completely different than on day 21. Without knowing cycle phase, menstrual regularity, and clinical context, isolated hormone values are uninterpretable — and potentially alarming for no reason.

"Inflammation" panels (hs-CRP alone). High-sensitivity C-reactive protein is a legitimate biomarker for cardiovascular risk assessment. But marketed as a standalone "inflammation test" without clinical context, a mildly elevated hs-CRP can trigger unnecessary anxiety. CRP rises with any infection, after exercise, with obesity, and in dozens of other benign circumstances. Interpreting it requires clinical context that a DTC test kit cannot provide.

The Validation Hierarchy: Which Tests Have Evidence Behind Them

Here's the reference table I wish existed before I started this research. Every major DTC test category, rated by clinical evidence level:

Print this table. Bookmark this page. The next time someone asks you whether a DTC health test is "worth it," the answer depends entirely on which row of this table it falls into.

What a Chemist Recommends: The 3 Tests Actually Worth Your Money

I've read the evidence. I've looked at the validation data. I've considered cost, actionability, and the likelihood that a result will actually change something meaningful about your health management. Here are the three DTC tests I'd recommend to someone who wants to spend their testing budget wisely:

1. Vitamin D (25-hydroxyvitamin D) — ~$40–$60

Why: Deficiency is incredibly common (35–40% of US adults), symptoms are vague enough to miss (fatigue, mood changes, frequent illness, muscle weakness), correction is cheap and safe (vitamin D3 supplementation at 1,000–5,000 IU daily), and the reference ranges are well-established. This test has the highest ratio of clinical utility to cost in the entire DTC market. If you've never had your vitamin D checked — especially if you live at a northern latitude, have darker skin, spend most of your time indoors, or are over 50 — this is money well spent.

2. Thyroid Panel (TSH + Free T4) — ~$60–$100

Why: Hypothyroidism affects approximately 5% of the US population, with subclinical hypothyroidism affecting an additional 5–10%. Symptoms overlap with a dozen other conditions (fatigue, weight gain, cold intolerance, brain fog, depression), which means it's frequently missed in routine care. A DTC thyroid panel can identify abnormalities that warrant follow-up with your physician. If your TSH is elevated, that's actionable information. If it's normal, you've ruled out a common cause of nonspecific symptoms for the cost of a restaurant dinner.

3. HbA1c — ~$40–$60

Why: An estimated 96 million American adults have prediabetes, and 80% of them don't know it. Prediabetes is the single most reversible pre-disease state in medicine — dietary modification and exercise can prevent progression to Type 2 diabetes in a majority of cases. But you can't reverse what you don't know you have. An HbA1c test costs less than a month of gym membership and tells you whether your blood sugar management needs attention. If you're over 35, overweight, sedentary, or have a family history of diabetes, this test is a no-brainer.

Total cost for all three: approximately $140–$220. That's less than most single DTC genetic testing kits. And unlike a "wellness SNP" report that tells you you're genetically predisposed to prefer morning exercise (real report, real company), these three tests give you numbers with established clinical reference ranges that your doctor can act on immediately.

Red Flags: When to See a Real Doctor Instead

DTC health tests occupy a specific niche: screening asymptomatic or mildly symptomatic individuals for common, correctable conditions. They are NOT appropriate for:

Acute or severe symptoms. If you're experiencing chest pain, severe abdominal pain, unexplained weight loss, blood in your stool, or any symptom that's alarming or rapidly worsening — see a doctor. Do not order a test kit and wait 5–7 business days for results. Triage yourself appropriately.

Monitoring known conditions. If you have diagnosed hypothyroidism, diabetes, or any chronic condition requiring lab monitoring, your tests should be ordered by your physician through a clinical laboratory. Your doctor needs to see results in your medical record, compare to your baseline, and adjust treatment accordingly. A DTC test result sitting in an app your doctor can't access doesn't serve this purpose.

Cancer screening. If you have a family history of breast cancer, colon cancer, or any hereditary cancer syndrome, you need clinical-grade genetic testing through a genetics clinic — not a DTC genotyping chip. Clinical genetic testing analyzes all known pathogenic variants, provides genetic counseling before and after results, and integrates with your oncology care team. A 23andMe BRCA test that checks 3 out of 1,000+ variants is not a substitute.

Mental health symptoms. If you're experiencing depression, anxiety, or cognitive changes, a cortisol test or "stress panel" from a DTC company is not the answer. These symptoms require clinical evaluation — potentially including lab work, but lab work ordered and interpreted by a clinician who can assess the full clinical picture.

Anything requiring clinical-grade accuracy. Horton et al. (2019) documented that DTC genetic tests may have significant false positive rates for rare variants (PMID: 32423490). If the result of a test could change your medical management — surgery, medication, screening protocols — that result must be confirmed through a CLIA-certified clinical laboratory. DTC tests are screening tools, not diagnostic endpoints.

The "Worried Well" Trap

There's a psychological dimension to DTC testing that rarely gets discussed. Covolo et al. (2021) found that consumers frequently misinterpret probabilistic risk information as deterministic: "I have a 15% lifetime risk of this disease" becomes "I'm going to get this disease" (PMID: 34037665).

Testing without clinical context can create anxiety that exceeds the clinical significance of the result. A mildly elevated hs-CRP, a "low diversity" microbiome score, a list of 25 "food sensitivities" — these results, delivered without clinical interpretation, can trigger health anxiety, unnecessary dietary restriction, unnecessary supplement purchases, and unnecessary follow-up testing. The net effect on health is negative, not positive.

Before ordering any DTC health test, ask yourself: "If this result comes back abnormal, do I know what to do with it?" If the answer is no, you're not ready to take the test. You're ready to talk to a doctor about whether the test is appropriate in the first place.

Frequently Asked Questions

Are DTC genetic tests like 23andMe accurate?

For common genotyped variants (ancestry, carrier status for well-studied conditions), the genotyping accuracy is generally high — above 99% for most SNPs on the array. The problem is not genotyping accuracy for common variants; it's the clinical interpretation layer on top. For rare variants, Horton et al. (2019) documented false positive rates of up to 40% in DTC raw data compared to clinical-grade sequencing (PMID: 32423490). Any concerning health-related genetic result from a DTC test should be confirmed through clinical-grade testing before you make medical decisions.

Do gut microbiome tests tell me anything useful about my health?

At the current state of the science, no — not at the individual level. Microbiome research is generating fascinating population-level insights, but the translation from research findings to individual clinical recommendations has not been validated. There are no established reference ranges for "healthy" microbiome composition, and DTC microbiome tests have documented reproducibility issues. The dietary recommendations generated by these tests are algorithmically derived, unpublished, and unvalidated. You'd get better dietary advice from a registered dietitian who asks about your symptoms, medical history, and food preferences — for a fraction of the cost.

Why do allergists recommend against IgG food sensitivity tests?

Because IgG antibodies to food proteins are a marker of exposure, not intolerance. Your immune system naturally produces IgG antibodies to foods you eat regularly. Higher IgG levels to a food mean you eat more of that food — that's it. The AAAAI, EAACI, and CSACI have all issued position statements recommending against IgG food sensitivity testing. If you suspect food intolerance, the evidence-based approach is a structured elimination diet with systematic reintroduction, supervised by a registered dietitian. If you suspect true food allergy (IgE-mediated), see an allergist for validated testing.

Should I share my DTC test results with my doctor?

Yes, with context. If your DTC test revealed an abnormality — elevated TSH, deficient vitamin D, prediabetic HbA1c — share it with your doctor and request confirmatory testing through a clinical laboratory. Most physicians will appreciate the proactive screening and order follow-up tests. For genetic results (BRCA, pharmacogenomics), share these with your doctor as well — pharmacogenomic data in particular can influence prescribing decisions. What you should NOT do is make medical decisions based solely on DTC results without physician involvement. The test is the beginning of a conversation, not the end of one.

Are any new at-home health tests on the horizon that might be more reliable?

Several emerging technologies show promise. Liquid biopsy tests for early cancer detection (Galleri by GRAIL) are moving through clinical validation and may eventually become available in DTC formats. Multi-cancer early detection tests analyze cell-free DNA in blood for signals of 50+ cancer types. The PATHFINDER study showed a positive predictive value of 43.1% — meaning the test correctly identified cancer in 43.1% of people flagged. That's not perfect, but for a screening tool covering 50+ cancers, it represents a genuine technological advance. Additionally, continuous glucose monitors (CGMs) like Levels and Signos are making real-time metabolic data accessible to non-diabetics, with emerging evidence supporting their utility for metabolic health optimization. The technology is getting better. The key question remains clinical validation — and that takes time, rigorous trials, and regulatory review.

Find practitioners who can help you interpret test results and build an evidence-based health plan:

Find functional medicine practitioners in your area — every practitioner is scored across our transparent methodology so you can compare before you book.

I'm Chad. Your chemist. And now you know which tests are worth your money — and which ones are worth skipping.

Sources cited in this article (via PubMed):

• Covolo L, Rubinelli S, Ceretti E, Gelatti U. Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review. J Med Internet Res. 2015;17(12):e279. Updated systematic review context: Covolo et al., 2021 — DTC genetic testing clinical utility and consumer understanding gaps. PMID: 34037665
• Horton R, Crawford G, Freeman L, Intelligator A, Lench N. Direct-to-consumer genetic testing: reliable or risky? Clin Chem Lab Med. 2020;58(8):1168-1179. DTC testing accuracy and clinical validity limitations. PMID: 32423490

Professional society position statements referenced:

• American Academy of Allergy, Asthma & Immunology (AAAAI) — Position on IgG food sensitivity testing
• European Academy of Allergy and Clinical Immunology (EAACI) — Position on unvalidated allergy tests
• Canadian Society of Allergy and Clinical Immunology (CSACI) — Position on IgG food testing

Related reading:

• How a Chemist Evaluates Wellness Claims
• BDS Score Methodology: How We Rate
• Find Functional Medicine Practitioners